ADMA Biologics Inc - Common Stock (NQ:ADMA)

CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds ADMA Biologics Investors of Securities Class Action Lawsuit Deadline on August 10, 2026

August 10, 2026

From Faruqi & Faruqi, LLP

ADMA DEADLINE TOMORROW: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

Performance

52-Week Range 50.2% below 52-week high

10.18

7.2152W Low 20.4652W High

1 Week 3.1% below 1-week high

9.981W Low 10.511W High

ADMA Biologics Inc - Common Stock (ADMA) traded between $7.21 and $20.46 over the past 52 weeks and last traded at $10.18, 50.2% below its 52-week high. Over the past week it ranged between $9.98 and $10.51.

Past 12 Months

N/A

+11.4%

+13.5%

-1.9%

-43.1%

-30.0%

1M +$1.04

3M +$1.21

6M -$0.20

YTD -$7.70

1Y -$4.37

ADMA was -30.0% over the past year, -1.9% over six months, -43.1% year to date.

12 Months vs Market

ADMA

-30.0%

DIA

+12.4%

SPY

+17.4%

QQQ

+23.9%

IWM

+13.7%

Over the past 12 months ADMA returned -30.0% versus DIA (Dow) +12.4%, SPY (S&P 500) +17.4%, QQQ (Nasdaq 100) +23.9% and IWM (Russell 2000) +13.7%.

Volume & Liquidity 0.61× 3-mo avg

Today 1,627,440 3-mo avg 2.7M

2.7M

3.4M

2.7M

3.8M

YTD

4.2M

4.0M

ADMA most recently traded 1,627,440 shares against a 3-month average daily volume of 2.7M.

More News

August 09, 2026

ADMA Biologics 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Reminds Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From Kahn Swick & Foti, LLC

ADMA BIOLOGICS CLASS ACTION DEADLINE AUGUST 10th: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

ADMA Biologics (NASDAQ:ADMA) Shares Slide as Q2 Results Miss Estimates ↗

August 05, 2026

Via Chartmill

August 07, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 07, 2026

Via Newsfile

ADMA Biologics Deadline: Rosen Law Firm Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 07, 2026

From The Rosen Law Firm, P.A.

ADMA Biologics Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against ADMA Biologics, Inc. - ADMA

August 07, 2026

From SkyMedia, LLC

ADMA BIOLOGICS DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 06, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 06, 2026

From Schall, Brown & Schwartz LLP

ADMA Biologics Q2 Earnings Call Highlights ↗

August 05, 2026

Via MarketBeat

ADMA Biologics Reports Second Quarter 2026 Financial Results and Provides Business Update

August 05, 2026

From ADMA Biologics, Inc.

ADMA Biologics (ADMA) Shareholder Alert: Kehoe Law Firm Investigates Potential Fiduciary Duty Breaches

August 05, 2026

Via Newsfile

DEADLINE NEXT WEEK: Berger Montague Advises ADMA Biologics, Inc. (NASDAQ: ADMA) Investors to Contact the Firm Before August 10, 2026

August 05, 2026

From Berger Montague

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 04, 2026

From Kahn Swick & Foti, LLC

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in ADMA Biologics, Inc. of Class Action Lawsuit and Upcoming Deadlines – ADMA

August 04, 2026

From Pomerantz LLP

SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against ADMA Biologics, Inc. (ADMA)

August 04, 2026

From Bernstein Liebhard LLP

ADMA BIOLOGICS CLASS ACTION DEADLINE REMINDER: Bragar Eagel & Squire, P.C. Urges ADMA Biologics, Inc. Stockholders to Contact the Firm Regarding Their Rights Before August 10th

August 03, 2026

From Bragar Eagel & Squire

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

August 03, 2026

Via Newsfile

ADMA BIOLOGICS DEADLINE: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

August 03, 2026

ADMA Investors Have Opportunity to Lead ADMA Biologics, Inc. Securities Fraud Lawsuit with SBS Law

August 03, 2026

From Schall, Brown & Schwartz LLP

ADMA DEADLINE: ROSEN, THE FIRST FILING FIRM, Encourages ADMA Biologics, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 10 Deadline in Securities Class Action First Filed by the Firm – ADMA

July 31, 2026

ADMA Biologics, Inc. Notice of August 10, 2026 Application Deadline for Class Action Lawsuit - Contact Lewis Kahn, Esq. at Kahn Swick & Foti, LLC, Before Application Deadline

July 31, 2026

Via Newsfile

ADMA Biologics (NASDAQ: ADMA) Investigated for Potential Federal Securities Laws Violations – Lowey Dannenberg, P.C.

July 31, 2026

From Lowey Dannenberg, P.C.